# Filing Detail

Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-21-126214
Filing Date
2021-10-14
Accepted
2021-10-14 16:02:51
Documents
6

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B5 | tm2129111-4_424b5.htm | 424B5 | 493553
2 | GRAPHIC | lg_rezolute-4clr.jpg | GRAPHIC | 24804
3 | GRAPHIC | tm2129111d1-fc_exist4clr.jpg | GRAPHIC | 245848
4 | GRAPHIC | tm2129111d1-fc_circulat4clr.jpg | GRAPHIC | 153201
5 | GRAPHIC | tm2129111d1-lc_glucoseclr.jpg | GRAPHIC | 314209
6 | GRAPHIC | tm2129111d1-bc_vascu4clr.jpg | GRAPHIC | 172754
| Complete submission text file | 0001104659-21-126214.txt |  | 1750037

Mailing Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065
Business Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065 650-847-1919
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 424B5 | Act: 33 | File No.: 333-251498 | Film No.: 211323419
SIC: 2834 Pharmaceutical Preparations